Comparison of Pidrolax plus paraffin versus Pidrolaxin the treatment of pediatric functional constipation

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N179

Enrollment

Registered

2023-01-01

Start date

2023-01-20

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric functional constipation. Functional intestinal disorder, unspecified

Interventions

Intervention 1: Intervention group 1: will receive 0.7 geram in kilogeram Pidrolaxin in day for 3 months. Intervention 2: Intervention group 2: will receive 0.7 geram in kilogeram in day of Pidrolaxin

Eligibility

Sex/Gender

All

Age

2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Outpatients with a history of functional constipation (at least 3 months) 2 to 18 years

Exclusion criteria

Exclusion criteria: Non-functional constipation Resistance to treatment in the first month hypothyroidism hyreshprong disease Known disorders cardiac, renal and neurological Colon surgery history Patients with secondary constipation due to chronic disease such as endocrine, metabolic or neurological diseases

Design outcomes

Primary

Measure	Time frame
Frequency of defecation. Timepoint: In week. Method of measurement: Physical examination.;Painful defecation. Timepoint: In week. Method of measurement: Physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mojtaba Hashemi

Arak University of Medical Sciences

hashemi@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026